Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
CEO: Amir Avniel. Company website
Beyond Air, Inc. (XAIR) trades at $4.39, down 22.98% on the day, as of Sep 20, 2026 15:00 UTC.
Beyond Air, Inc. has a market capitalisation of $22.25M, calculated from the live XAIR share price and shares outstanding.
XAIR has no meaningful price-to-earnings ratio: Beyond Air, Inc. lost $5.42 per share over the last twelve months, and a P/E is only defined on positive earnings.
Beyond Air, Inc. generated revenue of $6.92M over the trailing twelve months, which puts the stock at 3.21 times sales.
XAIR has traded between $0.61 and $10.50 over the past 52 weeks, and the last price is 58.2% below that high.
No. Beyond Air, Inc. is loss-making, with a net margin of -447.73% over the trailing twelve months.
Wall Street analysts rate XAIR Buy, with an average price target of $1.00, 77.2% below the current price.
Beyond Air, Inc. is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US .
Amir Avniel is the chief executive of Beyond Air, Inc., which employs 107 people.
QFI Terminal shows XAIR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open XAIR in Terminal See plans